Hepatitis-B virus endemicity: Heterogeneity, catastrophic dynamics and control

Nature Medicine

Volumn 7, Issue 5, 2001, Pages 619-624

  Medley, Graham F ^a   Lindop, Nathan A ^b   Edmunds, W John ^c   Nokes, D James ^a,d  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b Xilinx Scotland   (United Kingdom)

^c CDSC   (United Kingdom)

^d KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROL SYSTEM; DYNAMICS; ENDEMIC DISEASE; FEEDBACK SYSTEM; GENETIC HETEROGENEITY; HEPATITIS B VIRUS; IMMUNIZATION; INFECTION CONTROL; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS TRANSMISSION;

CARRIER STATE; HEPATITIS B; HUMANS; PREVALENCE;

EID: 0035041293     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/87953     Document Type: Article

References (36)

1. Maynard, J.E., Kane, M.A., Alter, M.J. & Hadler, S.C. Hepatitis B by immunisation: global perspectives. In Viral Hepatitis and Liver Disease (ed. Zuckerman, A.J.) 967-969 (Alan R. Liss Inc., New York, 1988).
2. Mayans, M.V. et al. Do bedbugs transmit hepatitis B? Lancet 343, 761-763 (1994).
3. Mayans, M.V. et al. Risk factors for the transmission of hepatitis B virus to Gambian children. Lancet 336, 1107-1109 (1990).
4. Whittle, H.C. et al. Hepatitis B virus infection in two Gambia villages. Lancet 1, 1203-1206 (1983).
5. Schreeder, M.J. et al. Prevalence of hepatitis B in selected Alaskan Eskimo villages. Am. J. Epidemiol. 118, 543-549 (1983).
6. Mortimer, P.P. & Miller, E. Antenatal screening and targeting should be sufficient in some countries. Br. Med. J. 314, 1036-1037 (1997).
7. O'Connell, T. et al. Prevalence of hepatitis-B anti-core antibody in the Republic of Ireland. Epidemiol. Infect. 125, 701-704 (2000).
8. Anderson, R.M. & May, R.M. Infectious Diseases of Humans: Dynamics and Control. (Oxford University Press, 1991).
9. Anderson, R.M., Medley, G.F. & Nokes, D.J. Preliminary analyses of the predicted impacts of various vaccination strategies on the transmission of hepatitis B virus. In The Control of Hepatitis B: The Role of Prevention in Adolescence. (ed. Bennet, D.L.) 95-130 (Cower Medical, London, 1992).
10. Edmunds, W.J., Medley, G.F. & Nokes, D.J. The transmission dynamics and control of hepatitis 8 virus in a developing country. Stats. Med. 15, 2215-2233 (1996).
11. Zhao, S., Xu, Z. & Lu, Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int. J. Epidemiol. 29, 744-752 (2000).
12. Williams, J.R., Nokes, D.J., Medley, G.F. & Anderson, R.M. The transmission dynamics of hepatitis-B in the UK: a mathematical model for evaluating costs and effectiveness of immunisation programmes. Epidemiol. Infect. 116, 71-89 (1996).
13. Edmunds, W.J. Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies. Comm. Dis. Pub. Health 1, 221-228 (1998).
14. Edmunds, W.J., Medley, G.F. & Nokes, D.J. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stats. Med. 18, 3263-3282 (1999).
15. McMahon, B.J. et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J. Infect. Dis. 151, 599-603 (1985).
16. Hyams, K.C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin. Infect. Dis. 20, 992-1000 (1995).
17. Edmunds, W.J., Medley, G.F., Nokes, D.J., Hall, A.J. & Whittle, H.C. The influence of age on the development of the hepatitis B carrier state. Proc. Roy. Soc. Lond. Ser. B. 253, 197-201 (1993).
18. Panagiotopoulos, T., Antoniadou, I. & Valassi-Adam, E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. Br. Med. J. 319, 1462-1467 (1999).
19. Dushoff, J. Incorporating immunological ideas in epidemiological models. J. Theor. Biol. 180, 181-187 (1996).
20. Dushoff, J., Huang, W. & Castillo-Chavez, C. Backwards bifurcations and catastrophe in simple models of fatal diseases. J. Math. Biol. 36, 227-248 (1998).
21. Hadeler, K.P. & Castillo-Chavez, C. A core group model for disease transmission. Math. Biosci. 128, 41-58 (1995).
22. van den Driessche, P. & Watmough, J. A simple SIS epidemic model with a backward bifurcation. J. Math. Biol. 40, 525-540 (2000).
23. Wodarz, D. & Nowak, M.A. Specific therapy regimes could lead to long-term immunological control of HIV. Proc. Nat Acad. Sci. USA 96, 14464-14469 (1999).
24. Kuznetsov, Y.A. & Piccardi, C. Bifurcation analysis of periodic SEIR and SIR epidemic models. J. Math. Biol. 32, 109-21 (1994).
25. Greenhalgh, D., Diekmann, O. & de Jong, M.C.M. Subcritical endemic steady states in mathematical models for animal infections with incomplete immunity. Math. Biosci. 165, 1-25 (2000).
26. Simon, C.P. & Jacquez, J. Reproduction numbers and the stability of equilibria of SI models for heterogeneous populations. SIAM J. Appl. Math. 52, 541-576 (1996).
27. Huang, W., Cooke, K.L. & Castillo-Chavez, C. Stability and bifurcation for a multiple-group model for the dynamics of HIV/AIDS transmission. SIAM J. Appl. Math. 52, 835-854 (1992).
28. Hadeler, K.P. & van den Driessche, P. Backward bifurcation in epidemic control. Math. Biosci. 146, 15-35 (1997).
29. Poston, T. & Stewart, I. Castrophe Theory and Its Application. (Pitman, San Francisco, 1978).
30. Hill, A.V. The immunogenetics of human infectious diseases. Ann. Rev. Immunol. 16, 593-617 (1998).
31. Thursz, M.R. et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. New Engl. J. Med. 332, 1995-1999 (1995).
32. Edmunds, W.J. et al. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol. Infect. 117, 313-325 (1996).
33. Wilson, J.N., Nokes, D.J. & Carman, W.F. Predictions of the emergence of vaccine-resistant hepatitis B in The Gambia using a mathematical model. Epidemiol. Infect. 124, 295-307 (2000).
34. Gay, N.J. & Edmunds, W.J. Developed countries could pay for hepatitis B vaccination in developing countries. Br. Med. J. 316, 1457 (1998).
35. Okoth, F.A. et al. Seroepidemiological study for HBV markers and anti-delta in Kenya. East Afr. Med. J. 68, 515-523 (1991).
36. McLean, A.R. & Blumberg, B.S. Modelling the impact of mass vaccination against hepatitis B. I Model formulation and parameter estimation. Proc. Roy. Soc. Lond. B 256, 7-15 (1994).